Skip to main content

2 Result(s)

within Masahiko Ajiro Remove this filter Oncology Remove this filter

and

  1. Article

    Open Access

    The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer

    Currently, only limited knowledge is available regarding the phenotypic association between fibroblast growth factor receptor 3 (FGFR3) alterations and the tumor microenvironment (TME) in bladder cancer (BLCA).

    Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsu**o… in Molecular Cancer (2023)

    Download PDF (9543 KB) View Article

  2. Article

    Open Access

    Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy

    Chronic infection with Kaposi’s sarcoma-associated herpes virus (KSHV) in B lymphocytes causes primary effusion lymphoma (PEL), the most aggressive form of KSHV-related cancer, which is resistant to convention...

    Tetsunori Sakamoto, Masahiko Ajiro, Akira Watanabe, Shingo Matsushima… in BMC Cancer (2023)

    Download PDF (4579 KB) View Article